Stanford center on Type 1 diabetes after acute pancreatitis
The Stanford Clinical Center for the Study of Type 1 Diabetes in Acute Pancreatitis
Stanford follows adults who have had acute pancreatitis to understand how and when Type 1 diabetes develops using blood tests, mixed-meal and glucose testing, and MRI.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11234156 on NIH RePORTER |
What this research studies
If you join, you'll be enrolled in the DREAM observational cohort and followed over time with medical history, blood draws, and scheduled clinic visits. You may be asked to join optional tests such as a mixed-meal tolerance test, a frequently sampled intravenous glucose tolerance test, and MRI scans to measure pancreas structure and function. The team will also collect immune and cellular samples to study how pancreatitis might trigger diabetes and will run secondary and ancillary studies as the cohort completes enrollment. Care is coordinated by a multidisciplinary team from pancreatology, endocrinology, radiology, and immunology at Stanford.
Who could benefit from this research
Good fit: Adults (21 and older) who have experienced acute pancreatitis, especially those with new or unstable ('brittle') diabetes, are the best fit for participation.
Not a fit: People under 21, those without a history of acute pancreatitis, or individuals with long-standing diabetes unrelated to pancreatitis are unlikely to benefit directly from this project.
Why it matters
Potential benefit: This work could help detect diabetes earlier after pancreatitis and lead to better monitoring or prevention strategies for affected patients.
How similar studies have performed: Observational cohort and metabolic-testing approaches have helped identify diabetes risk patterns before, but applying them specifically to diabetes after acute pancreatitis is relatively new.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Park, Walter Gwang-Up — Stanford University
- Study coordinator: Park, Walter Gwang-Up
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.